These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26332574)

  • 1. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
    Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
    Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.
    van Duijn PW; Marques RB; Ziel-van der Made ACJ; van Zoggel HJAA; Aghai A; Berrevoets C; Debets R; Jenster G; Trapman J; van Weerden WM
    Prostate; 2018 Sep; 78(13):1013-1023. PubMed ID: 30133757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
    Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
    Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.
    Wang Z; Xu D; Ding HF; Kim J; Zhang J; Hai T; Yan C
    Oncogene; 2015 Sep; 34(38):4975-84. PubMed ID: 25531328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gata3 antagonizes cancer progression in Pten-deficient prostates.
    Nguyen AH; Tremblay M; Haigh K; Koumakpayi IH; Paquet M; Pandolfi PP; Mes-Masson AM; Saad F; Haigh JJ; Bouchard M
    Hum Mol Genet; 2013 Jun; 22(12):2400-10. PubMed ID: 23428429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3.
    Janssen A; Hoellenriegel J; Fogarasi M; Schrewe H; Seeliger M; Tamm E; Ohlmann A; May CA; Weber BH; Stöhr H
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2812-22. PubMed ID: 18408187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells.
    Lin H; Zhang Y; Wang H; Xu D; Meng X; Shao Y; Lin C; Ye Y; Qian H; Wang S
    Cancer Gene Ther; 2012 Dec; 19(12):845-51. PubMed ID: 23037807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
    Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
    Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.
    Li Y; Su J; DingZhang X; Zhang J; Yoshimoto M; Liu S; Bijian K; Gupta A; Squire JA; Alaoui Jamali MA; Bismar TA
    J Pathol; 2011 May; 224(1):90-100. PubMed ID: 21381033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.
    Lu TL; Huang YF; You LR; Chao NC; Su FY; Chang JL; Chen CM
    Am J Pathol; 2013 Mar; 182(3):975-91. PubMed ID: 23313138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.
    Zhabyeyev P; Das SK; Basu R; Shen M; Patel VB; Kassiri Z; Oudit GY
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H978-H990. PubMed ID: 29373036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
    Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
    Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.
    Han XG; Li Y; Mo HM; Li K; Lin D; Zhao CQ; Zhao J; Tang TT
    Tumour Biol; 2016 Jul; 37(7):8857-67. PubMed ID: 26749283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells.
    Hwang ES; Park KK
    Biosci Biotechnol Biochem; 2010; 74(5):961-7. PubMed ID: 20460721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride treatment alters MMP-2 and -9 gene expression and activity in the rat ventral prostate.
    Delella FK; Justulin LA; Felisbino SL
    Int J Androl; 2010 Feb; 33(1):e114-22. PubMed ID: 19508332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.
    Shin YJ; Kim JH
    PLoS One; 2012; 7(1):e30393. PubMed ID: 22272343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo.
    Hong JH; Ahn KS; Bae E; Jeon SS; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(2):147-52. PubMed ID: 16389264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
    Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
    Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.
    Ito Y; Ishiguro H; Kobayashi N; Hasumi H; Watanabe M; Yao M; Uemura H
    Prostate; 2015 Jul; 75(10):1009-19. PubMed ID: 25917126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.